Editas Medicine (EDIT) FCF Margin Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 6,066.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.19 Mn |
| Jun 30, 2025 | -84,183.00 |
| Mar 31, 2025 | -26,839.00 |
| Dec 31, 2024 | 13,956.00 |
| Sep 30, 2024 | -9.03 Mn |
| Jun 30, 2024 | -126,286.00 |
| Mar 31, 2024 | -379,623.00 |
| Dec 31, 2023 | 31,618.00 |
| Sep 30, 2023 | -64,219.00 |
| Jun 30, 2023 | -98,030.00 |
| Mar 31, 2023 | 60,090.00 |
| Dec 31, 2022 | -102,079.00 |
| Sep 30, 2022 | -12.15 Mn |
| Jun 30, 2022 | 53,487.00 |
| Mar 31, 2022 | 65,877.00 |
| Dec 31, 2021 | -34,405.00 |
| Sep 30, 2021 | -57,592.00 |
| Jun 30, 2021 | -1.03 Mn |
| Mar 31, 2021 | -18,740.00 |
| Sep 30, 2020 | -30,328.00 |
| Jun 30, 2020 | -168,007.00 |
| Mar 31, 2020 | -1.11 Mn |
| Dec 31, 2019 | 224,933.00 |
| Sep 30, 2019 | 76,559.00 |
| Jun 30, 2019 | -75,764.00 |
| Mar 31, 2019 | -15,750.00 |
| Dec 31, 2018 | 112,723.00 |
| Sep 30, 2018 | 173,600.00 |
| Jun 30, 2018 | -1.20 Mn |